<DOC>
	<DOCNO>NCT01127516</DOCNO>
	<brief_summary>The hypothesis investigation rate isolation resistant nosocomial pathogen explain combination measure include , among thing , antimicrobial drug use , infection control effort , patient mix antimicrobial stewardship effort . The short term goal investigation improve understanding relationship antimicrobial stewardship program effort ( actual antimicrobial drug use ) , infection control effort incidence rate MSSA , MRSA , h-VISA SA-MICcreep . The long term goal investigation design intervention improve antimicrobial drug use decrease cross-transmission resistant bacteria , result decrease rate infection cause resistant hospital organism .</brief_summary>
	<brief_title>The Causes Interpretation Low-level Resistance Staphylococcus Aureus</brief_title>
	<detailed_description>Study Design We propose survey clinical pharmacist , infectious disease practitioner clinical microbiologist 53 hospital summer 2009 characterize hospital policy toward isolation SA-MICcreep investigate relationship SA-MICcreep vancomycin use . Specifically , determine ( 1 ) hospital attempt isolate SA-MICcreep ( 2 ) method ( ) test SA susceptibility vancomycin , ( 3 ) interpretative criterion MICs vancomycin whether policy toward differential treatment isolate SA-MICcreep . In addition determine ( 1 ) relationship SA-MICcreep vancomycin use ( 2 ) relationship hospital patient demographic SA-MICcreep . A pilot study ( Dec. 2008 ) find 7 8 hospital survey determine vancomycin MIC Staphylococcus aureus . However interpretation finding , action take , differ hospital . This may newly describe phenomenon , professional organization yet issue guideline regard interpretation isolates ( 6 ) . We measure vancomycin use follow method hospital : - Days therapy/1000 patient day . - Mean duration vancomycin therapy ( day ) . - Proportion adult patient receive vancomycin ( % ) . - Vancomycin `` Intensity Index '' : The product # 2 # 3 . We also measure use antibacterial drug use treat infection cause Staphylococcus aureus include linezolid daptomycin drug may reduce isolation SA-MICcreep . The survey instrument include request follow information : 1 . Does clinical microbiology laboratory make attempt identify MIC creep clinical isolates Staphylococcus aureus ? 1 . If yes , policy begin ? 2 . Are Staphylococcus aureus isolates test ( i.e. , MSSA MRSA ) MRSA ? 3 . Are clinical isolate routinely test , select isolates ( e.g. , request ID , blood isolates , isolates ICU patient , etc . ) 4 . What method ( ) use determine MIC vancomycin ? 5 . What MIC think warrant concern ? ( e.g. , 1.0 , 1.5 , 2.0 mcg/ml ) ? 6 . What action , , take function MIC vancomycin ? 7 . Is `` aggressive '' therapy vancomycin attempt isolate concern identify , alternative therapy recommend routinely implement ? 8 . If alternative therapy routinely administer , therapy ?</detailed_description>
	<criteria>Adult inpatient Pediatric inpatient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Susceptibility test</keyword>
	<keyword>Antimicrobial stewardship</keyword>
</DOC>